Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
N Engl J Med 2014;371:993-1004
Final FDA action on KPV is still pending
TB-500s actin-driven promotion of cell migration addresses the early, structural phase of tissue repair getting cells to the site of damage and supporting their organisation
& Currie, P
Unlike TGA-approved products, pharmacy-compounded products are not clinically evaluated by the independent regulator for safety, quality or efficacy and there have been increasing reports of patients experiencing adverse effects from their use
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
